Table 2. Indication for Induction.
High-Dose Vaginal Misoprostol (n=20) | Concentrated Oxytocin + Low-dose Vaginal PGE1 (n=18) | p value | |
---|---|---|---|
|
|
|
|
Fetal Anomaly/Aneuploidy | 65.0% (13/20) | 66.7% (12/18) | |
Preterm Premature Rupture of Membranes | 20.0% (2/20) | 5.5% (1/18) | |
Fetal Demise | 10.0% (4/20) | 16.7% (3/18) | |
Maternal Indication | 5.0% (1/20) | 11.1% (2/18) | 0.831 |